J. Berman

发表

Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI).

P. Sampson, N. Kaplan, D. Awrey, 2009, Bioorganic & medicinal chemistry letters.

2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabI.

David D. Manning, P. Sampson, N. Kaplan, 2009, Bioorganic & medicinal chemistry letters.

Use of "N-in-One" dosing to create an in vivo pharmacokinetics database for use in developing structure-pharmacokinetic relationships.

K. Adkison, J. Berman, J. Shaffer, 1999, Journal of pharmaceutical sciences.

Rapid synthesis of novel dipeptide inhibitors of human collagenase and gelatinase using solid phase chemistry

M. Lambert, M. Foley, D. Drewry, 1996 .

Potent dipeptide inhibitors of the pp60c-src SH2 domain.

P. Charifson, K. Lackey, L. Shewchuk, 1998, Journal of medicinal chemistry.

Identification of NAE Inhibitors Exhibiting Potent Activity in Leukemia Cells: Exploring the Structural Determinants of NAE Specificity.

A. Schimmer, P. Gunning, S. Dhe-Paganon, 2011, ACS medicinal chemistry letters.

1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists.

M. K. James, T. Rimele, R. G. Sherrill, 2001, Bioorganic & medicinal chemistry letters.

Structural proteomics-a new driving force in drug discovery From the identification of first inhibitors to lead optimisation , having access to high-resolution protein structures is a key advantage in the search for new therapeutic agents

C. Burks, M. Schmid, R. Hui, 2022 .

2-(Anilinomethyl)imidazolines as α1-adrenoceptor agonists: the identification of α1A subtype selective 2′-carboxylic acid esters and amides

M. J. Bishop, J. Speake, D. Minick, 2001 .

Preparation of pentafluorophenyl esters of FMOC protected amino acids with pentafluorophenyl trifluoroacetate

Michael D. Green, J. Berman, 1990 .

SYNTHESIS OF CYCLIC AND ACYCLIC PARTIAL RETRO-INVERSO MODIFIED ENKEPHALINS

M. Goodman, J. Berman, 1984 .

Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger".

M. K. James, L. Miller, R. Carr, 1996, Journal of medicinal chemistry.

α1-Adrenoceptor Agonists: The Identification of Novel α1A Subtype Selective 2′-Heteroaryl-2-(phenoxymethyl)imidazolines

M. J. Bishop, J. Speake, J. Berman, 2002 .

α-Dicarbonyls as “non-charged” arginine-directed affinity labels. Novel synthetic routes to α-dicarbonyl analogs of the PP60c-src SH2 domain-targeted phosphopeptide Ac-Tyr(OPO3H2)-Glu-Glu-Ile-Glu

P. Charifson, D. Sternbach, J. Berman, 1996 .

Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput.

K. Adkison, J Berman, K Halm, 1997, Journal of medicinal chemistry.

Synthesis of the Nakanishi Ring-Locked Retinoid

Jamie B. Côté, Tan D. Quach, Andrey P. Demenev, 2011, International journal of medicinal chemistry.

High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds.

M H Tarbit, M. Tarbit, J Berman, 1998, Current opinion in chemical biology.

Cyclization of protected N-acylhydroxyguanidine to 3-amino-1,2,4-oxadiazole

Jamie B. Côté, J. You, J. Berman, 2011 .

Tripeptides as selective inhibitors of src-SH2 phosphoprotein interactions

T. Gilmer, R. Crosby, K. Alligood, 1995, Letters in Peptide Science.

Involvement of pp60c-src with two major signaling pathways in human breast cancer.

M. Luther, T. Gilmer, T. J. Lansing, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor

Vladimir Romanov, Molly B. Schmid, N. Kaplan, 2012, Antimicrobial Agents and Chemotherapy.

Discovery of a Potent and Selective α1A Antagonist

D. Drewry, K. Adkison, J. Berman, 2002 .

Structure-Activity Relationship of Flavin Analogues That Target the Flavin Mononucleotide Riboswitch.

R. Batey, H. Kaur, Q. Vicens, 2018, ACS chemical biology.

A High Throughput Fluorogenic Substrate for Stromelysin (MMP‐3)

C. Wagner, Michael D. Green, J. Berman, 1994, Annals of the New York Academy of Sciences.

Structure–Activity Relationship of Flavin Analogues That Target the Flavin Mononucleotide Riboswitch

R. Batey, H. Kaur, Q. Vicens, 2018 .

In vitro activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics

N. Kaplan, D. Awrey, J. Yethon, 2013, Journal of chemotherapy.

Synthesis of cyclic and acyclic partial retro-inverso modified enkephalins.

M. Goodman, J. Berman, 2009, International journal of peptide and protein research.

Cyclic and acyclic partial retro-inverso enkephalinamides: Mu receptor selective enzyme resistant analogs.

P. Schiller, M. Goodman, J. Berman, 1983, Biochemical and biophysical research communications.

Peptide sweeteners. 5. Side-chain homologues relating zwitterionic and trifluoroacetylated amino acid anilide and dipeptide sweeteners.

M. Kawai, M. Goodman, J. Berman, 1982, Journal of medicinal chemistry.

Peptide inhibitors of src SH3-SH2-phosphoprotein interactions.

Larry J. Shampine, Patel, P. Charifson, 1995, The Journal of biological chemistry.